Table 2:

Meta-analysis outcomes

Outcome	All Patients		Deconstructive		Reconstructive		P Deconstructive versus Reconstructive
	Event Rate (95% CI)	I2	Event Rate (95% CI)	I2	Event Rate (95% CI)	I2
All patients
Immediate occlusion	75.0 (55.0–88.0)	83	88.0 (47.0–98.0)	86	53.0 (31.0–74.0)	71	<.0001
Long-term occlusion	87.0 (74.0–94.0)	82	88.0 (35.0–99.0)	91	81.0 (64.0–91.0)	62	<.0001
Perioperative morbidity	12.0 (9.0–16.0)	0	12.0 (7.0–18.0)	0	4.0 (2.0–10.0)	0	.04
Perioperative mortality	8.0 (6.0–11.0)	0	10.0 (6.0–17.0)	0	4.0 (2.0–10.0)	0	.11
Recurrence	7.0 (5.0–10.0)	0	5.0 (2.0–10.0)	0	5.0 (2.0–11.0)	0	.89
Retreatment	3.0 (2.0–6.0)	0	5.0 (2.0–10.0)	0	3.0 (1.0–8.0)	0	.25
Long-term good clinical outcome	84.0 (65.0–94.0)	89	86.0 (68.0–95.0)	68	92.0 (86.0–95.0)	0	.10
Patients with rupture
Immediate occlusion	78.0 (55.0–91.0)	78	94.0 (84.0–98.0)	0	43.0 (18.0–73.0)	57	<.0001
Long-term occlusion	88.0 (83.0–92.0)	0	95.0 (86.0–98.0)	0	83.0 (74.0–90.0)	0	.02
Perioperative morbidity	16.0 (11.0–22.0)	10	14.0 (8.0–23.0)	0	7.0 (3.0–17.0)	0	.82
Perioperative mortality	11.0 (8.0–16.0)	0	13.0 (8.0–22.0)	0	7.0 (3.0–15.0)	0	.82
Rebleed	9.0 (6.0–13.0)	0	9.0 (4.0–20.0)	12	7.0 (3.0–14.0)	0	.75
Recurrence	8.0 (5.0–13.0)	0	6.0 (2.0–13.0)	0	7.0 (2.0–17.0)	1	1.00
Retreatment	5.0 (3.0–8.0)	0	6.0 (2.0–13.0)	0	5.0 (2.0–15.0)	0	.25
Long-term good clinical outcome	79.0 (68.0–87.0)	59	83.0 (62.0–94.0)	64	88.0 (79.0–94.0)	0	.19
Patients without rupture
Immediate occlusion	80.0 (48.0–94.0)	74	94.0 (68.0–99.0)	28	57.0 (25.0–84.0)	65	<.0001
Long-term occlusion	86.0 (69.0–94.0)	64	97.0 (81.0–100.0)	0	68.0 (47.0–83.0)	31	<.0001
Perioperative morbidity	6.0 (3.0–12.0)	0	7.0 (2.0–19.0)	0	7.0 (2.0–19.0)	0	.58
Perioperative mortality	4.0 (2.0–9.0)	0	4.0 (1.0–18.0)	0	5.0 (1.0–15.0)	0	1.00
Recurrence	7.0 (4.0–13.0)	0	4.0 (1.0–18.0)	0	7.0 (2.0–20.0)	0	1.00
Retreatment	4.0 (2.0–9.0)	0	4.0 (1.0–18.0)	0	5.0 (1.0–15.0)	0	1.00
Long-term good clinical outcome	95.0 (89.0–98.0)	0	93.0 (76.0–98.0)	0	94.0 (84.0–98.0)	0	1.00